Avanzanite Raises €32M to Boost Rare Disease Treatments
Avanzanite Bioscience raises €32M to expand access and accelerate development of rare disease therapies.
Latest articles
Software
Development
4 min
Getting Ready for the Inevitable
AI
VC
2 min
Solena Materials Raises $6.7M for Sustainable Fibres
AI
AI startups
5 min
4 Reasons Over 90% of Enterprise AI Startups Fail
AI
VC
1 min
Cavell Raises €1.5M to Streamline Medical Admin with AI
Growth
Marketing
5 min
How to Post on LinkedIn: Grow Your Network Fast
VC
Marketing
2 min
Paramark Raises $8M to Reinvent Marketing Measurement
AI
VC
2 min
Ceto Raises $4.8M to Modernize Maritime with AI
Marketing
Roundtable
15 min
Expert Opinions on Effective Marketing in 2025 | Part 2
AI
VC
1 min